-

Redwire Awarded NASA Contract to Expand Pharmaceutical Drug Development in Space for Future Commercialization

JACKSONVILLE, Fla.--(BUSINESS WIRE)--Redwire Corporation (NYSE: RDW), a leader in space infrastructure for the next-generation space economy, has been awarded a NASA contract to launch four additional pharmaceutical drug investigations to the International Space Station using the company’s innovative Pharmaceutical In-space Laboratory (PIL-BOX). The NASA-funded investigations aim to manufacture high-value seed crystals which could inform pharmaceutical manufacturing operations aboard the space station and future commercial space stations in low Earth orbit (LEO).

“NASA has been an instrumental partner and customer as we’ve scaled our pharmaceutical drug manufacturing program significantly over the last year,” said John Vellinger, Redwire’s President of In-Space Industries. “Additional PIL-BOX investigations from NASA and commercial partners will enable Redwire to optimize the infrastructure to launch, test, manufacture, and return high-value space enabled pharmaceutical products and establish a new market in LEO”

With 28 units flown and processed to date, PIL-BOX provides pharmaceutical researchers with novel and flexible services to leverage the microgravity environment to grow small-batch crystals of protein-based pharmaceuticals and other key pharmaceutically relevant molecules. Previous spaceflight investigations indicate that growing crystals in space could yield a more uniform product with fewer imperfections, which can improve the drug discovery and development process. Previous investigations have focused on unlocking insights to improve treatments for cardiovascular disease, obesity, and diabetes.

About Redwire

Redwire Corporation (NYSE: RDW) is a global space infrastructure and innovation company enabling civil, commercial, and national security programs. Redwire’s proven and reliable capabilities include avionics, sensors, power solutions, critical structures, mechanisms, radio frequency systems, platforms, missions, and microgravity payloads. Redwire combines decades of flight heritage and proven experience with an agile and innovative culture. Redwire’s approximately 750 employees working from 17 facilities located throughout the United States and Europe are committed to building a bold future in space for humanity, pushing the envelope of discovery and science while creating a better world on Earth. For more information, please visit redwirespace.com.

Contacts

Media Contact:
Tere Riley
tere.riley@redwirespace.com
321-831-0134

OR

Investors:
investorrelations@redwirespace.com
904-425-1431

Redwire Corporation

NYSE:RDW

Release Versions

Contacts

Media Contact:
Tere Riley
tere.riley@redwirespace.com
321-831-0134

OR

Investors:
investorrelations@redwirespace.com
904-425-1431

More News From Redwire Corporation

Redwire Elects The Honorable Frank Calvelli to Board of Directors

JACKSONVILLE, Fla.--(BUSINESS WIRE)--Redwire Corporation (NYSE: RDW), a global leader in aerospace and defense technology solutions, today announced that its Board of Directors has elected The Honorable Frank Calvelli as its newest member, effective March 12, 2026. Calvelli previously served as Assistant Secretary of the Air Force for Space Acquisition and Integration and was the Pentagon’s first service acquisition executive for U.S. Space Force space systems and programs. In this role, Calvel...

Redwire Awarded Prime Contract to Build First National Security Satellite for Belgian Defence, in Close Collaboration with Aerospacelab

KRUIBEKE, Belgium--(BUSINESS WIRE)--Redwire Corporation (NYSE: RDW), a global leader in space and defence technology solutions, today announced it has been awarded a prime contract by Belgian Defence to build and deliver the country’s first national security satellite that will provide secure, resilient, and independent access to critical space-based services aimed at and in support of national defence priorities. The mission—known as MATTEO—is commissioned by the Belgian Federal Government and...

NASA Awards Redwire $4 Million In Additional Funding to Support Trailblazing Drug Development in Microgravity

JACKSONVILLE, Fla.--(BUSINESS WIRE)--Redwire Corporation (NYSE: RDW), a global leader in space and defense technology solutions, today announced that NASA has awarded the company an additional $4 million to support new drug development investigations on the International Space Station (ISS) using Redwire’s Pharmaceutical In-space Laboratory (PIL-BOX) technology. This additional funding expands an existing task order under a $25 million, five-year indefinite-delivery/indefinite-quantity contract...
Back to Newsroom